DMAA is a synthetic stimulant that activates your sympathetic nervous system, the same “fight or flight” system triggered by adrenaline. It raises blood pressure, constricts blood vessels, and produces a burst of energy and focus that made it wildly popular in pre-workout supplements before the FDA moved to pull it from the market starting in 2012.
How DMAA Works in Your Body
DMAA (1,3-dimethylamylamine) is classified as a sympathomimetic amine, meaning it mimics the effects of your body’s stress-response hormones. Specifically, it blocks the reuptake of noradrenaline, the chemical messenger that ramps up alertness, heart rate, and blood pressure. By preventing your nerve cells from reabsorbing noradrenaline after it’s released, DMAA lets that signal stay active longer and hit harder. The result is a pronounced stimulant effect that users describe as intense focus, elevated energy, and a feeling of being “dialed in.”
Animal studies confirmed this mechanism: when researchers chemically disabled the sympathetic nervous system in rats, DMAA’s effects on heart rate and blood pressure largely disappeared. That tells us it isn’t acting on its own so much as amplifying a system your body already has.
What You Actually Feel
The core effects of DMAA are cardiovascular and neurological. It raises heart rate and blood pressure through vasoconstriction, a tightening of blood vessels that forces the heart to work harder. Users typically report a rush of energy within 15 to 30 minutes of taking it, along with heightened focus, suppressed appetite, and a tingling or jittery sensation.
The intensity is what separated DMAA from caffeine in the minds of many gym-goers. Where caffeine provides a broad, moderate lift, DMAA delivers a sharper, more aggressive spike. That also means the downsides are sharper. Common complaints include racing heart, anxiety, headaches, and nausea during the active window, followed by fatigue and irritability as the effects wear off. Combining DMAA with caffeine or other stimulants (as most pre-workout formulas did) amplifies both the highs and the risks. The Dutch National Institute for Public Health specifically warned that stacking DMAA with other sympathomimetic ingredients produces compounding stimulant effects.
The Cardiovascular Risk
DMAA’s effect on the cardiovascular system is the primary safety concern. Because it constricts blood vessels and raises blood pressure, it places extra strain on the heart. In otherwise healthy people, this might produce nothing worse than an uncomfortable pounding sensation. But in people with undiagnosed heart conditions, high blood pressure, or other risk factors, the consequences have been severe. Reports linked to DMAA-containing products include heart attacks, strokes, and deaths, which is what ultimately drove regulatory action.
The risk scales with dose, and because DMAA appeared in supplements with inconsistent labeling and highly variable concentrations, many users had no reliable way to know how much they were taking.
Why the FDA Banned It
Starting in 2012, the FDA issued warning letters to companies selling DMAA-containing supplements, stating that these products violated federal law. The agency’s position is straightforward: DMAA does not qualify as a dietary ingredient because it is not a vitamin, mineral, amino acid, or herb, and it has no history of use as a food prior to 1994.
In 2013, the FDA escalated enforcement by administratively detaining two of the most popular DMAA products on the market, OxyElite Pro and Jack3d, after their manufacturer USPLabs refused voluntary compliance. The agency also seized DMAA products from Hi-Tech Pharmaceuticals. That case went to federal court, and in April 2017 a judge ruled the products were adulterated and ordered them destroyed.
The “Natural” Geranium Claim
Supplement companies marketed DMAA as “geranamine” or “geranium extract,” claiming it occurred naturally in the geranium plant (Pelargonium graveolens). This framing was critical to their legal argument that DMAA qualified as a botanical dietary ingredient. Independent testing has largely dismantled that claim.
A study published in Drug Testing and Analysis examined eight commercial geranium extracts from China and the Middle East using high-sensitivity mass spectrometry. None contained detectable DMAA at a threshold as low as 10 parts per billion. The researchers then analyzed DMAA extracted from 13 different supplements and compared it to synthetic DMAA standards. The chemical fingerprints were indistinguishable. The DMAA in every supplement tested was racemic, meaning it contained equal proportions of mirror-image molecules, a hallmark of industrial synthesis rather than biological production. The conclusion: the DMAA in supplements is synthetic, not plant-derived.
Its History Before Supplements
DMAA was not invented by the supplement industry. Eli Lilly was awarded U.S. patents for its synthesis in 1944 and 1945. Beginning in 1971, Lilly marketed it as a nasal decongestant, which makes pharmacological sense: a compound that constricts blood vessels can shrink swollen nasal passages. It was eventually withdrawn from that use and largely forgotten until supplement manufacturers rediscovered it in the mid-2000s and began adding it to pre-workout and weight-loss products.
Names to Watch For on Labels
DMAA still circulates in some products sold online or in stores outside FDA enforcement reach. It appears under many names on ingredient labels:
- 1,3-dimethylamylamine
- 1,3-dimethylpentylamine
- 4-methylhexan-2-amine
- Methylhexanamine (MHA)
- Geranamine
- Forthane
If you see any of these on a supplement label, the product contains DMAA regardless of whether it claims to be a “geranium extract.”
DMAA and Drug Testing
The World Anti-Doping Agency lists DMAA as a prohibited substance under category S6.B: Specified Stimulants. It is banned in competition, meaning athletes can test positive during events. The “specified” designation means a positive test may allow for a reduced sanction under certain conditions, but it does not excuse athletes from responsibility. WADA’s strict liability rule holds that athletes are accountable for everything in their system regardless of intent. Multiple military and competitive athletes have failed drug tests because of DMAA in supplements they didn’t realize contained it, which is one reason the labeling problem matters beyond consumer health.